References

 

  1. Blaylock RL. (2002) New developments in the prevention and treatment of neurodegenerative diseases using nutraceuticals and metabolic stimulants. JANA, vol. 5, no. 1, pg. 15-32.
  2. Worley PF, Baraban JM, Snyder SH. (1987) Beyond receptors: multiple second-messenger systems in brain. Ann Neurol. 21:217-229.
  3. Lipton SA. (1993) Prospects for clinically tolerated NMDA antagonist: open-channel blockers and alternative redox states of nitric oxide. Trends Neurosci. 16:527-532.
  4. Keller JN, Mark RJ, et al. (1997) 4-hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes. Neuroscience. 80:685-696.
  5. Ames BN, et al. (1993) Oxidants, antioxidants and degenerative diseases of aging. Proc Nat Acad Sci USA. 90:7915-7922.
  6. Lane DP, Midgley CA, et al. (1995) On the regulation of the p53 tumor suppressor, and its role in the cellular response to DNA damage. Philos Trans R. Soc Biol Sci. 347:83-87.
  7. Hamos JE, DeGennaro LJ, Drachman DA. (1989) Synaptic loss in Alzheimer’s disease and other dementias. Neurology. 39:355-361.
  8. Behl C, Davis JB, et al. (1994) Hydrogen peroxide mediates amyloid beta protein toxicity. Cell. 77:817-827.
  9. Mattson MP, Cheng B, Davis D, et al. (1992) B-amyloid peptides destabilizes calcium homeostasis and renders human cortical neurons vulnerable to excitotoxicity. J Neurosci. 12:376-389.
  10. Stoll G, Jander S. (1993) The role of microglia and macrophages in the pathophysiology of the CNS. Prog Neurobiol. 1995; 58:233-247.
  11. Banati RB, Gehrmann J, et al. Cytotoxicity of microglia. Glia. 7:111-118.
  12. Sarin S, Gupta KD. (1997) Alterations in lipid composition and neuronal injury in primates following chronic aluminum exposure. Biol Trace Elem Res. 58:133-143.
  13. Julka D, Gill. (1996) Effect of aluminum on regional brain antioxidant defense status in Wistar rats. Res Exp Med (Berl). 196:187-194.
  14. Deloncle R, Guillard O, et al. (1995) Modification of the blood-brain barrier through chronic intoxication by aluminum glutamate. Possible role in the etiology of Alzheimer’s disease. Bio Trace Elem Res. 47:227-233.
  15. Mundy WR, Freudenrich TM, Kodavanti PR. (1997) Aluminum potentiated glutamate-induced calcium accumulation and iron-induced oxygen free radical formation in primary neuronal cultures. Mol Chem Neuropathol. 32:41-57.
  16. Moore PB, Edwardson JA, et al. (1997) Gastrointestinal absorption of aluminum is increased in Down’s syndrome. Biol Psychiatry. 41:488-492.
  17. Coburn JW, Mischel MG, et al. (1991) Calcium citrate markedly enhances aluminum absorption from aluminum hydroxide. Am J Kidney Dis. 17:708-711.
  18. Ruiz F, Alverez G, et al. (1998) Protection by pyruvate and malate against glutamate-mediated neurotoxicity. Neuroreport. 9:1277-1282.
  19. Sakhis S, Bruce A, et al. (1997) Induction of tumor suppressor p53 and DNA fragmentation in organotypic hippocampal cultures following excitotoxin treatment. Ex Neurol. 145:81-88.
  20. Sanchez-Carbente MR, Massieu L. (1999) Transient inhibition of glutamate uptake in vivo induces neurodegeneration when energy metabolism is impaired. J Neurochem. 72:129-138.
  21. Heyes MP, Achim CL, et al. (1996) Human microglia convert L-tryptophan into the neurotoxin quinolinic acid. Biochem J. 320:595-597.
  22. Piani D, Frei K, et al. (1991) Murine brain macrophages induce NMDA receptor mediated neurotoxicity in vitro by secreting glutamate. Neurosci Lett. 133:159-162.
  23. Popovic M, Caballero-Bleda M, et al. (1998) Importance of immunological and inflammatory processes in the pathogenesis and therapy of Alzheimer’s disease. Intern J Neuroscience. 95:203-236.
  24. Murphy T, Parikh A, et al. (1989) Arachidonic acid metabolism in glutamate neurotoxicity. Ann NY Acad Sci. 559:474-477.
  25. Klergis A, McGreer PL. (1997) a-amyloidprotein enhances macrophage production of oxygen free radicals and glutamate. Neurosci Res. 49:229-235.0
  26. Levi B, Werman MJ. (1998) Long-term fructose consumption accelerates glycation and several age-related variables in male rats. J Nutr. 128:1442-1449.
  27. Cassina R, Radi LC (1996) Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch Biochem Biophysic. 328:309-316.
  28. Smith MA, Harris PLR, et al. (1997) Widespread peroxynitrite-mediated damage in Alzheimer’s disease. J Neurosci. 17:2653-2657.
  29. Keller JN, Hanni KB, Kindy MS. (2000) Oxidized high-density lipoprotein induces neuron death. Exp Neurology. 161:621-630.
  30. Schroeter H, Williams RJ, et al. (2000) Phenolic antioxidants attenuate neuronal cell death following uptake of oxidized low-density lipoprotein. Free Radic Biol Med. 29:1222-1233.
  31. Flott-Rahmel B, Schurmann M, et al. (1998) Homocysteic and homocysteine sulphinic acid exhibit excitotoxicity in organotypic cultures from rat brain. Eur J Pediatr. 157: (suppl):S112-S117.
  32. Li S, Mallory M, et al. (1997) Glutamate transporter alterations in Alzheimer’s disease are possibly associated with abnormal APP expression. J Neuropath Exp Neurol. 56:901-911.
  33. Berman SB, Hastings TG. (1997) Inhibition of glutamate transport in synaptosomes by dopamine oxidation and reactive oxygen species. J Neurochem. 69:1185-1195.
  34. Kort JJ. (1998) Impairment of excitatory amino acid transport in astroglial cells infected with human immunodeficiency virus type I AIDs. Res Human Retroviruses. 14:1329-1339.
  35. Bano S and Parihar MS. Reduction of lipid peroxidation in different brain regions by a combination of alpha-tocopherol and ascorbic acid. J Neural Trans. (1997) 104:1277-1286.
  36. Beal MF. (1994) Coenzyme Q10 and niacinamide are neuroprotective against mitochondrial toxins in vivo. Neurology. (suppl 2): A177.
  37. Martin, A, et al. (2000) Effect of fruits, vegetables or vitamin E-rich diet on vitamins E and C distribution in peripheral and brain tissues: Implications for brain function. J Gerontol Biol Sci. 55(3):144-151.
  38. Youdim KA and Joseph JA. (2001) A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: A multiplicity of effects. Free Radic Biol Med. 30(6):583-594.
  39. Packer L. (1996) Prevention of free radical damage in the brain: Protection by alpha-lipoic acid. In: Packer L, Hiramatsu M, Yoshikawa T, eds. Free Radicals in Brain Physiology and Disorders; NY: Academic Press; 19-34.
  40. Busse E, Zimmer G, et al. (1992) Influence of alpha lipoic acid on intracellular glutathione in vitro and in vivo. Arzneimittel-Forschung. 42:829-831.
  41. Gotz ME, Dirr A, et al. (1994) Effect of lipoic acid on redox state of coenzyme Q in mice treated with 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine and diethyl dithiocarbamate. Eu J Pharmacol. 266:291-300.
  42. Handelman GJ, Han D, et al. (1994) Alpha-lipoic acid reduction by mammalian cells to the dithol form, and release into the culture medium. Biochem Pharmacol. 47:1725-1730.
  43. Rajakrishnan V, Viswanathan P, et al. (1999) Neuroprotective role of curcumin from Curcuma longa on ethanol-induced brain damage. Phytother Res. 13:571-574.
  44. Reiter RJ, Tan D, et al. (2000) Actions of melatonin in the reduction of oxidative stress: a review. J Biomed. 7:444-458.
  45. Deiana M, Auroma OI, et al. (1999) Inhibition of peroxynitrite dependent DNA base modification and tyrosine nitration by the extra virgin olive oil-derived antioxidant hydroxytyrosol. Free Radic Biol Med. 26:726-769.
  46. Anderson RF, Amarasinghe G, et al. (2000) Reduction in free radical-induced DNA strand breaks and base damage through fast chemical repair by flavonoids. Free Radic Res. 33:91-103.
  47. Joosten E, Lesafre E, et al. (1997) Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer’s disease? J Gerontol A Biol Sci Med Sci. 52:M76-M79.
  48. Carmel R, Gott PS, et al. (1995) The frequently low cobalamin levels in dementia usually signify treatable metabolic, neurologic and electrophysiologic abnormalities. Eur J Haematol. 54:245-253.
  49. Bonoczk P, Gulyas B, et al. (2000) Role of sodium channel inhibition in neuroprotection: effect of vinepocetine. Brain Res Bull. 53:245-254.
  50. Ruiz F, Alverez G, et al. (1998) Protection by pyruvate and malate against glutamate mediated neurotoxicity. Neuroreport. 9:1277-1282.
  51. Brustovetsky N, Brustovetsky T, Dubinsky JM. (2001) On the mechanism of neuroprotection by creatine and phosphocreatine. J Neurochem. 76:425-434.
  52. Tordera M, Ferrandiz ML, Alcaraz MJ. (1994) Influence of anti-inflammatory flavonoids on degranulation and arachidonic acid release in rat neurtrophils. Z Natuforsch. 49:235-240.
  53. Yoshino S, et al. (1987) Abstract: Effect of dietary fish oil derived fatty acids on inflammation and immunological processes. Fed Proc 46:1173.
  54. Tate, GA, et al. (1988) Suppression of monosodium urate crystal-induced acute inflammation by diets enriched with gamma-linolenic acid and eicosapentaenoic acid. Arthritis Rheum 31 (12): 1543-51.
  55. Vander Jagt DL, Hunsaker LA, et al. (1997) Inactivation of glutathione reductase by 4-hydroxynonenal and other endogenous aldehydes. Biochem Pharmacol. 53:1133-1140.
  56. Adachi T, Ischido M, Kunimoto M. (2000) Studies in protective factors for cell death of cerebellar neurons induced by methylmercury. Neurotoxicol. 21:615-640.
  57. Lee JH, Kange HS, Roh J. (1999) Protective effects of garlic juice against embryotoxicity of methylmercuric chloride administered to pregnant Fischer 344 rats. Yonsie Med J. 40:483-489.
  58. Seppanen K, Kantola M, et al. (2000) Effect of supplementation with organic selenium on mercury status as measured by mercury in pubic hair. J Trace Elem Med Biol. 14:84-87.
  59. Packer L, Witt EH, Tritschler JH. (1995) Alpha-lipoic acid as a biological antioxidant. Free Radic Biol Med. 19:227-250.
  60. Walker M. (1998) The Medical Mushroom Properties of Coriolus Versicolor or PSK. Townsend Letter.
  61. Torisu M, et al. (1990) Significant prolongation of disease-free period gained by polysaccharide K (coriolus). Cancer Immunology and Immunotherapy, 31:261-268.
  62. Tsukagoshi S, et al. (1984) Krestin (PSK), Cancer Treatment Reviews. 11:131-155.
  63. Adachi K, et al. (1988) Blood pressure-lowering activity present in the fruit body of Grifola frondosa (maitake). Chem Pharm Bull, 36(3): 1000-1006.
  64. Borchers AT, et al. (1999) Mushrooms, tumors, and immunity. Proceedings of the Society of Exp Biol Med, 221(4): 281-93.
  65. Hobbs C. (1995) Medicinal Mushrooms, an Exploration of Tradition, Healing, and Culture; Botanica Press, Santa Cruz, CA.
  66. Jong SC, et al. (1990) The medicinal value of the mushroom Grifola. World J of Micro and Biotech, 6:227-235.
  67. Kubo K, et al. (1994) Anti-diabetic activity present in the fruit body of Grifola frondosa (maitake). Biol Pharm Bull, 17(8):1106-1110.
  68. Lieberman S and Babal K. (1997) Maitake: King of Mushrooms, Keats: New Caanan, CT.
  69. Mizuno T and Cun Z. (1995) Maitake, Grifola frondosa: Pharmacological Effects. Food Rev Int, 11(1):135-149.
  70. Nanba H. (1996) Maitake D-fraction: healing and preventing potentials for cancer. Townsend Letter for Doctors and Patients.
  71. Ohtsuru M. (1992) Anti-obesity activity exhibited by orally administered powder of maitake mushroom (Grifola frondosa). Anshin. 198-200.
  72. Wasser SP and Weis AL. (1999) Medicinal Properties of Substances Occurring in higher basidiomycetes Mushrooms: Current Perspectives (Review). Int J of Med Mushrooms. Vol. 1(1):31-62.
  73. Yamada Y, et al. Anti-tumor effect of orally administered extracts from fruitbody of Grifola frondosa (maitake). Chemotherapy, 1990; 38:790-796.
  74. Zhuang C and Mizuno T. (1999) Biological Responses from Grifola frondosa, Int J of Med Mushrooms, Vol. 1(4):317-324.
  75. Schmidt M, et al. Beyond Antibiotics: 50 Ways to Boost Immunity and Avoid Antibiotics, North Atlantic Books: Berkeley, CA, 1994.
  76. Walker M. (1997) Olive Leaf Extract, Kensington Pub.
  77. (1953) Amoebic dysentery and H. antidysenterica, Indian Pharmaceutical Codex.
  78. (1966) Antiprotozoal activity and H. antidysenterica, Indian Pharmacopia.
  79. Dey D, Das MN, (1988) Pharmacognosy of antidysenteric drugs of Indian medicine, Acta Botanica Indica, 16:2, 216-226.
  80. (1991) Antiprotozoal, antiamoebic activity and H. antidysenterica, International Association of Traditional Asian Medicine, pp 4-5.
  81. Ghutani KK, Vais RM, et al. (1980) Steroidal alkaloids from H. antidysenterica, Phytochemistry, 1990; 2913, 969-972. H. antidysenterica, Nagajun, p. 77-84.
  82. (1981) Phytochemistry & Pharmacology of H. anti-dysenterica, Indian Medical Gazzette, Exn (5): P. 179-186
  83. (1989) Salimuzzaman S, Shamshuddin BA. Isolation & structure of holarrifine, a new alkaloid from the bark of H. antidysenterica. Pakistan Journal of Scientific & Indust. Res., 32:1, 1-3.
  84. (1989) Salimuzzaman S, Shamshuddin BA. Isolation & structure of holarrifine, a new alkaloid from the bark of H. antidysenterica. Pakistan Journal of Scientific & Indust. Res., 32:1, 1-3.
  85. Balanos JP, Almeida A, et al. (1997) Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases. J Neurochem. 68:2227-2240.
  86. Glick JL. (1990) Dementias: the role of magnesium deficiency and an hypothesis concerning the pathogenesis of Alzheimer’s disease. Med Hypothesis. 31:211-225.
  87. Whyte KF, Addis GJ, Whitesmith R, Reid JL. (1987) Adrenergic control of plasma magnesium in man. Clin Sci (Lond), 72(1):135-8.
  88. Weglicki WB, Phillips TM, et al. (1992) Magnesium deficiency elevates circulating levels of inflammatory cytokines and endothelin. Mol Cell Biochem. 110:169-173.
  89. Much G, Gerlach M, et al. (1998) Advanced glycation end products in neurodegeneration: more than early markers of oxidative stress? Ann Neurol. 44: (3 suppl):S85-S88.
  90. Mohr D, Bowry VW, Sticker R. (1992) Dietary supplementation with coenzyme Q10 results in increased levels of circulating lipoproteins and increased resistance of human low-density lipoproteins to the initiation of lipid peroxidation. Biochem Biophys ACTA. 1126:247-253.
  91. Schoeter H, William RT, et al. (2000) Phenolic antioxidants attenuate neuronal cell death following uptake of oxidized low-density lipoproteins. Free Radic Biol Med. 29:1222-1233.
  92. Marshall K-A, Reist M, et al. (1999) The neuronal toxicity of sulfite plus peroxynitrite is enhanced by glutathione depletion: implications for Parkinson’s disease. Free Radic Biol Med. 27:515-520.
  93. Reddy SK, Husain K, et al. Dose response of ethanol ingestion on antioxidant defense system in rat brain subcellular fractions. Neurotoxicology, 1999; 20:977-988.
  94. Kang BY, Chung SW, et al. (1999) Inhibition of interleukin-12 production in lipopolysaccharide-activated macrophages by curcumin. Eur J Pharmacol. 19:191-195.
  95. Rothstein JD, Martin LJ, Kunel RW. (1992) Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med. 326:1464-1468.
  96. Jobin C, Bradham CA, et al. (1999) Curcumin blocks cytokine-mediated NF-kappa-B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol. 163:3474-3483.
  97. Sata M, Miyazaki T, et al. (1997) Quercetin, a bioflavonoid, inhibits the induction of interleukin 8 monocyte chemoattractant protein-1 expression by tumor necrosis factor alpha in cultured human synovial cells. J Rheumatol. 24: 1680-1684.
  98. Liang YC, Huang YT, et al. (1999) Suppression of inducible cyclooxygenase and inducible nitric oxide synthease by apigenin and related flavonoids in mouse macrophages. Carcinogenesis. 20:1945-1952.
  99. Shah SJ, Sylvester PW. (2005a) Gamma-tocotrienol inhibits neoplastic mammary epithelial cell proliferation by decreasing Akt and nuclear factor kappaB activity. Exp Biol Med, 230, 235-241.
  100. Jayadeep VR, Arun OS, et al. (2000) Changes in prostaglandin levels in alcohol toxicity: effect of curcumin and N-acetylcysteine. J Nutr Biochem. 11:509-514.
  101. Agarwal R, Diwanay S, et al. (1999) Studies on immunomodulatory activity of Withania somifera (Ashwagandha) extracts in experimental immune inflammation. J Ethnopharmacol. 67:27-35.
  102. Beal MF, Hyman BT, et al. (1993) Do energy deficits in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci. 16:125-131.
  103. Calvani M, Koverech A, Caruso G. (1993) Treatment of Mitochondrial Diseases. In: DiMauro S, Wallace DC, eds. Mitochondrial DNA in Human Pathology. NY: Raven Press; 173-198.
  104. Hagen TM, Ingersoll RT, et al. (1998) Acetyl-L-carnitine fed to old rats partially restores mitochondrial function and ambulatory activity. Proc Natl Acad Sci USA. 95:9562-9566.
  105. Ingersoll RT, Hagen TM, et al. (1999) (R) – alpha-lipoic acid-supplemented old rats have improved mitochondrial function, decreased oxidative damage and increased metabolic rate. FASEB J. 13:411-418.
  106. Beal MF, et al. Coenzyme Q10 and niacinamide are protective against mitochondrial toxins in vivo. Neuro 44 (Supp2), April 1994, A177.
  107. Kiluchi K, et al. (1997) Protective effects of methylcobalamin, a vitamin B12 analog, against glutamate-induced neurotoxicity in retinal cell culture. Invest Opthalmol Vis Sci. 38:848-851.
  108. Greenamyre JT, Garcia-Osuna M, et al. (1994) The endogenous cofactors, thiotic acid and dihydrolipoic acid, are neuroprotective against NMDA and malonic acid lesions of striatum. Neurosci Lett. 171:17-20.
  109. Rohdewald P. Pycnogenol. (1998) In: Rice-Evans CA, Packer L. eds., Flavonoids in health and Disease. NY: Marcel Dekker Inc; 405-436.
  110. Brewer LD, Thiabault V, et al. (2001) Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J Neurosci. 21:98-108.
  111. Mao X, Barger SW. (1998) Neuroprotection by dehydroepiandrosterone-sulphate: role of an NF KappaB-like factor. Neuroreport. 9:759-763.
  112. Kruman II, Culmsee C, et al. (2000) Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity. J Neurosci. 20:6920-6926.
  113. Skaper SC, Facci L, et al. (2001) Potentiation by histamine of synaptically mediated excitotoxicity in cultured hippocampal neurons: a possible role for mast cells. J Neurochem. 76:47-55.
  114. Niki E. (1987) Interactions of ascorbate and alpha-tocopherol. Third Conference of Vitamin C, Burns ET (Ed), NY Acad Sci498:186-199.
  115. Grill M, Memo M. (1999) Nuclear factor-kappaB/Rel proteins: a point of convergence of signaling pathways relevant in neuronal function and dysfunction. Biochem Pharmacol. 57:1-7.
  116. Holopainen I, Kontro P, Oja SS. (1989) Release of taurine from cultured cerebellar granule cells and astrocytes: co-release with glutamate. Neuroscience. 29:425-432.
  117. Fekkes D, van der Cammen TJ, et al. (1998) Abnormal amino acid metabolism in patients with early stage Alzheimer’s disease. J Neural Trans. 105:287-294.
  118. James MJ, Gibson RA, Cleland LG. (2000) Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr. 71 (suppl):343S-348S.
  119. Kaasik A, Kalda A, et al. (2001) Dehydroepiandrosterone sulphate prevents oxygen-glucose deprivation-induced injury in cerebellar granule cell culture. Neurosci. 102:427-432.
  120. Trieu VN, Uckun FM. (1999) Genistein is neuroprotective in murine models of familial amyotrophic lateral sclerosis and stroke. Biochem Biophys Res Commun. 258:685-688.
  121. Mukherjee SK, Adams JD Jr. (1997) The effects of aging and neurodegeneration on apoptosis-associated DNA fragmentation and the benefits of nicotinamide. Mol Chem Neuropathol. 32:59-74.
  122. Klein J, Chatterjee SS, Loffelholz K. (1997) Phospholipid breakdown and choline release under hypoxic conditions: inhibition by bilobalide, a constituent of Ginkgo biloba. Brain Res. 755:347-350.
  123. Gotoh F, Kitamura A, et al. (1972) Abnormal insulin secretion in amyotrophic lateral sclerosis. J Neurol Sci 16:201-207.
  124. Bidlack W, ed. (1999) Phytochemicals as BioActive Agents, Technomic Pub.
  125. Kamen B. (2001) Stabilized Rice Bran: The Perfect Polish For Your Diet. Alternative Medicine.
  126. Bucht G, et al. (1983) Changes in blood glucose and insulin secretion in patients with senile dementia of Alzheimer’s type. Acta Medica Scand 213:387-392.
  127. Brailowsky S, Montiel T. (1997) Motor function in young and aged hemiplegic rats: effects of Ginkgo biloba extract. Neurobiol Aging. 18:219-227.
  128. Fahn S. (1992) A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson’s disease. Ann Neurol, 32:S128-S132.
  129. B M, McGahon, Martin DSD, et al. (1999) Age-related changes in LTP and antioxidant defenses are reversed by an alpha-lipoic acid-enriched diet. Neurobiol Aging. 20:655-664.
  130. Keller JN, Hanni KB, Markesbery WR. (1999) Oxidized low-density lipoprotein induces neuronal death: implications for calcium, reactive oxygen species, and caspases. J Neurochem. 72:2601-2609.
  131. Tebbey PW, Bullke TM. (1990) Molecular basis for the immunosuppressive action of stearic acid [magnesium stearate] on T cells. Immunology; 70(3):379-384.
  132. Kirk CJ, et al. (2001) Steroids, Steroid Receptor. Biochem. Soc. Trans, 29:209-216.
  133. Stochmal A, Piacente S, Pizza C, Riccardis F, Leitz R and Oleszek W. (2001) Alfalfa (Medicago sativa L.) flavonoids. 1. Apigenin and luteolin glycosides from aerial parts. J Agric. Food Chem, 49:753-758.
  134. Hartwig UA, Maxwell CA, Joseph CM and Phillips DA. (1990) Chrysoeriol and luteolin released from alfalfa seeds induce nod genes in Rhizobium meliloti, Plant Physiology, Band 92, Heft, S. 116-122.
  135. (2000) Veggie Nutrients Dip in Tests. New House News Service, Washington, Omaha World-Herald. 6.
  136. Finley J, Matthys SL, Shuler T, et al. (1996) Selenium content of foods purchased in North Dakota. Nutr Res. 16:723-728.
  137. Zhi-bi L. (1979) The present status of pharmacological studies of Ling Zhi (ganoderma lucidum). Yao Hseuh Pao, 14 (3).
  138. Furuya T, Tsuda Y, Koga N, et al. Isolation of ganodosterone and ganoderic acids as liver function stimulants. Chem Abstr. 109 (18):156253q.
  139. Suffness M (ed). (1995) Taxol – Science and Applications. National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  140. Van Wyk BE, van Oudtshoorn B, Gericke N. (1997) Medicinal Plants of South Africa. Briza Publications: South Africa.
  141. Roberg SF. (1999/2001) Nature’s miracle. Roberg Alimentos Medicamentos da Natureza Ltda.
  142. Hertog MGL, Hollman PCH, Katan MJ and Kromhout D. (1993) Nutr Cancer. 20, 21-29.
  143. King A and Young G. (1999) Am Diet Assoc. 99, 213-218.
  144. Simonsohn B. Mango – divine fruit. http://www.sunfood.net/mangoarticle.html.
  145. Chamomile (Matricaria recutita). Turning Down the Heat On Hot Flashes. http://breastcancer.about.com/library/weekly/aa010601b.htm.
  146. Potera C. (1996) Biofilms invade microbiology. Science, Vol. 273.
  147. Resource library, Biofilm Systems Training Lab, etc.: http://www.erc.montana.edu/frmain.htm.
  148. (1999) Mycoplasma bacteria tied to chronic illness. Medical Sentinal, Vol. 4, No. 5, 172-75.
  149. (2000) Identification of mycoplasma in synovial fluid of arthritis patients. Journal of Clinical Microbiology, 38:90-93.
  150. Scott DW. (2001) Common mycoplasmas – now weaponized, pathogenic & deadly. Nexus Magazine, Vol. 8, No. 5.
  151. Stait SE and Leake DS. (1996) The effects of ascorbate and dehydroascorbate on the oxidation of low-density lipoprotein. Biochemical Journal. 320, (373-381).
  152. Mulleniz P, Denbesten PK, et al. (1995) Neurotoxicity of sodium fluoride in rats. Neurotoxicology Teratology. 17:169-177.
  153. Yoshino M, Murakami K. (1998) Interaction of iron with polyphenolic compounds: application to antioxidant characterization. Anal Biochem. 257:40-44.
  154. Panjwani NN. (1995) Virus-Induced Autoimmune Disease. Essays in Virology; 1(2), London School of Hygiene and Tropical Medicine, London, UK.
  155. Bai DL, Tang XC, He XC. (2000) Huperzine A: Potential Agent for Alzheimer’s Disease. Curr Med Chem, 7(3):355-74.
  156. Qian B, Zang X, Liu X. (1990) Effects of bee pollen on lipid peroxides and immune reponse in aging and malnourished mice. Chung Kuo Chung Yao Tsa Chih. 15(5):301-3, 319.
  157. Gollapudi S, Sharma HA, Aggarwal S, Byers LD, Ensley HE, Gupta S. (1995) Isolation of a previously unidentified polysaccharide (MAR-10) from Hyssop officinalis that exhibits strong activity against human immunodeficiency virus type 1. Biochem Biophys Res Comm. 5; 210(1):145-51.
  158. Kreis W, Kaplan MH, Freeman J, et al. (1990) Inhibition of HIV replication by Hyssop officinalis extract. Antiviral Research. 14:323-337.
  159. De Lorgeril M, Salen P, Martin JL, et al. (1999) Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation. 99:779-785.
  160. Piche LA, Draper HH, Cole PD. (1988) Malondialdehyde excretion by subjects consuming cod liver oil vs. a concentrate of n-3 fatty acids. Lipids. April 23(4):370-371.
  161. (2000) Brain, 123:733-45.
  162. Horwill, F. (1997) Does vitamin C supplementation improve physical performance? BMC News.
  163. Erasmus U. (1996) Fats that heal, fats that kill. Burnaby, BC, Canada: Alive Books.
  164. Do KQ, Herrling PL, Streit P, Cuenod M. (1988) Release of neuroactive substances: homocysteic acid as an endogenous agonist of the NMDA receptor. J Neural Transm, 72(3):185-90.
  165. Hoyer S, Nitsch R. (1989) Cerebral excess release of neurotransmitter amino acids subsequent to reduced cerebral glucose metabolism in early-onset dementia of Alzheimer type. J Neural Transm, 75(3):227-32.
  166. Bogdanov M, Heacock PN, Dowhan W. (2002) A polytopic membrane protein displays a reversible topology dependent on membrane lipid composition. EMBO J, 1; 21(9):2107-16.
  167. Booth PJ. (2001) Designing folding systems for membrane proteins. Albany Molecular Research Technical Reports. Vol. 6, No. 63.
  168. Kano-Sueoko T. (1999) Ethanolamine requirements for growth of mammalian epithelial cells in culture: reverse correlation with malignancy progression.
  169. Omura Y, Shimotsuura Y, Fukuoka A, Fukuoka H, Nomoto T. (1996) Significant mercury deposits in internal organs following the removal of dental amalgam. Acupunct Electrother Res. 21(2):133-60.
  170. Omura Y, Beckman SL. (1995) Role of mercury (Hg) in resistant infections. Acupunct Electrother Res. 20(3-4):195-229.
  171. Gouras GK, Xu H, et al. (2000) Testosterone reduces neuronal secretion of Alzheimer’s Beta-amyloid peptides. PNAS. 97:1202-1205.
  172. Sobel E, Dunn M, Davanipour Z, et al. (1996) Elevated risk of Alzheimer’s disease among workers with likely electromagnetic field exposure. Neurology, 47:1477-81.
  173. (2001) International Nanobacteria Minisymposium, http://www.nanobac.com/.
  174. Munch G, Mayer, Michaelis J. et al. Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of beta-amyloid peptide. Biochim Biophys Acya. 1997; 1360(1):17-29.
  175. Cherney Ra, Legg JT, McLean CA, et al. Aqueous dissolution of Alzheimer’s disease Ab amyloid deposits by biometal depletion. J Biol Chem. 1999; 274(33):23223-8.
  176. Huang X, Cuajungco MP, Atwood CS, et al. Cu(II) potentiation of Alzheimer Ab neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. J Biol Chem. 1999; 274(52):37111-6.
  177. Gulyaeva NV. Superoxide-scavenging activity of carnosine in the presence of copper and zinc ions. Biochemistry (Moscow). 1987; 52 (7 part 2):1051-4.
  178. Doble A. The role of excitotoxicity in neurodegenerative disease: implica¬tions for therapy. Pharmacol Ther. 1999; 81(3):163-221.
  179. Boldyrev A, Song R, Lawrence D, et al. Carnosine protects against exci¬totoxic cell death independently of effects on reactive oxygen species. Neuroscience. 1999; 94(2):571-7.
  180. Hipkiss AR, Preston JE, Himswoth DT, et al. Protective effects of carno¬sine against malondialdehyde-induced toxicity towards cultured rat brain endothelial cells. Neurosci Lett. 1997; 238(3):135-8.
  181. Nakagawa T, Yokozawa T, Terasawa K, Shu S, Juneja LR. Protective activity of green tea against free radical and glucose medicated protein damage. J Agric Food Chem. 2002; 50:2418-2422.
  182. (May 20, 2004) Journal of the European Moleclar Biology Organization, http://embojournal.npgjournals.com
  183. Yeungm F, Hoberg, JE, Ramsey, CS, Keller, MD, Jones, DR, Frye, RA, and Mayo, MW. (2004) Modulation of NF-kB-dependent transcription and cell survival by the SIRT1 deacetylase.EMBO J. 23(12):2369-2380.
  184. Jiang Q, Elson-Schwab I, Courtemanche C, et al. (2000) Gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc Natl Acad Sci USA 97(21): 11494-9.